BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20270314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20271107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Hong_Kong
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:HKT
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260521T235516
CREATED:20260223T171206Z
LAST-MODIFIED:20260223T171206Z
UID:2648-1779148800-1779407999@goodlifesci.sidley.com
SUMMARY:Sidley Sponsors the 2026 EU Pharma Law Forum
DESCRIPTION:Sidley is proud to sponsor and participate in the EU Pharma Law Forum\, the leading annual gathering of regulators\, in-house counsel\, policymakers\, and industry stakeholders shaping the future of European pharmaceutical law. \nView agenda here. \nSidley partner Anne Robert will be speaking on “How to Respond to Dawn Raids and Investigations.” Josefine Sommer will present on “Early Experiences from the HTA Regulation: Market Access Pricing and Reimbursement.” \nWe look forward to connecting with clients\, colleagues\, and industry leaders in Brussels to discuss the evolving legal landscape and the strategic considerations facing the pharmaceutical sector in 2026 and beyond.
URL:https://goodlifesci.sidley.com/event/sidley-sponsors-the-2026-eu-pharma-law-forum/
LOCATION:Steigenberger Icon Wiltcher’s\, Brussels
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20260609T133000
DTEND;TZID=America/Chicago:20260609T183000
DTSTAMP:20260521T235516
CREATED:20260416T223534Z
LAST-MODIFIED:20260518T205659Z
UID:2693-1781011800-1781029800@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences RoundtableThe Next Phase: Capital Strategy & Regulatory Alignment
DESCRIPTION:Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the current administration\, emerging technologies\, the investment landscape\, and more. \n \nFeatured Panel Topics \nPipelines and Product Launches: The New Normal for Strategic FDA and Pricing Planning\nThis panel will explore regulatory issues impacting activities critical to successful product launches and exits today\, including regulatory approval\, disease awareness and other pre-approval communications\, reimbursement planning in the era of MFN policy considerations\, relationships with investigators\, and continued access for clinical trial patients following product approval but before formulary access. \n– Torrey Cope\, Partner\, Food\, Drug and Medical Device\n– Meena Datta\, Partner\, Global Co-leader\, Healthcare \nRegulated\, Risky\, or Revolutionary? AI’s Role Across Drug Discovery\, Devices\, and Wellness\nThis panel will discuss regulatory issues\, business plans\, and risk-mitigation strategies for investors and companies as they scale and commercialize AI tools.\n \n– Deeona Gaskin\, Partner\, Food\, Drug and Medical Device and Former Associate Chief Counsel for Enforcement\, FDA\n– Scott Kaplan\, Senior Vice President\, Quality\, Regulatory and Patient Safety\, Baxter\n– Michael Rohr\, Partner\, Emerging Companies and Venture Capital\n– Luis Vilarin\, Vice President\, Legal\, Flagship Pioneer \nLife Sciences Dealmaking in 2026: Where Capital and Collaboration Converge\nThis panel will discuss the evolving biotech transaction landscape\, from venture financings to strategic alliances. \n– Jason Kropp\, Partner\, Emerging Companies and Venture Capital\n– Irina Margine\, Sector Lead\, Biotech Private Investments\, Wellington Management\n– Rosemary Reilly\, Partner\, Emerging Companies and Venture Capital \nFIRESIDE CHAT\n“Navigating the New Environment in DC: New Advocacy Options for Life Sciences Companies at FDA and Beyond” \nA conversation with former Senior White House Official Trent Morse and Becky Wood\, co-leader of Sidley’s FDA Practice and former FDA Chief Counsel. \nAgenda\nRegistration:  1:30 p.m. ET\nProgram: 2:00 p.m. ET\nReception: 5:00 p.m. ET \nWho Should Attend?\nExecutives\, Investors\, General Counsel\, and Company Counsel \n\n\n\n\n\n\nBy invitation only. Space is limited. For more information\, contact bosevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-2026/
LOCATION:Boston\, MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Hong_Kong:20260624T143000
DTEND;TZID=Asia/Hong_Kong:20260624T180000
DTSTAMP:20260521T235516
CREATED:20260519T204808Z
LAST-MODIFIED:20260519T204930Z
UID:2772-1782311400-1782324000@goodlifesci.sidley.com
SUMMARY:Hong Kong Life Sciences Roundtable
DESCRIPTION:Join us for an exclusive discussion on cross-border business development strategies for life sciences companies\, unlocking critical market opportunities at every stage. \n \nThe event will discuss: \n– Industry Outlook for Innovation\, Regulation and Commercialization\n– BIOSECURE Act Coalition: A Coordinated Effort to Influence How the Act is Implemented\n– Cross-border Licensing Outlook and Commercialization Strategies for Innovation\n– M&A for Biotech and Medtech Assets from the Hong Kong Listing Rules Perspectives\n– Evolving Post-listing Financing Landscape and Optimizing Capital Raising Strategies\n– Navigating the Highs and Lows in Life Sciences \n\n\n\nThis is an invitation only event. For more information\, please contact asiaevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/hong-kong-life-sciences-roundtable/
LOCATION:Sidley Hong Kong Office\, 39/F\, Two Int’l Finance Centre\, Central\, Hong Kong\, Hong Kong
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T130000
DTEND;TZID=America/Los_Angeles:20260722T163000
DTSTAMP:20260521T235516
CREATED:20260415T213237Z
LAST-MODIFIED:20260415T213237Z
UID:2688-1784725200-1784737800@goodlifesci.sidley.com
SUMMARY:Bay Area Life Sciences Roundtable
DESCRIPTION:Please join Sidley at SFMOMA for our annual Bay Area Life Sciences Roundtable\, an afternoon of thoughtful and engaging discussions addressing cutting-edge trends and hot topics. \n \nBy Invitation Only. Space is limited. For questions\, please contact sfevents@sidley.com. \nWho may be interested in attending:\nExecutives\, Directors\, Investors\, and In-House Counsel \nCLE credit for this program is pending.
URL:https://goodlifesci.sidley.com/event/bay-area-life-sciences-roundtable-2/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260825T140000
DTEND;TZID=Europe/Zurich:20260825T180000
DTSTAMP:20260521T235516
CREATED:20260521T211126Z
LAST-MODIFIED:20260521T211126Z
UID:2789-1787666400-1787680800@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2026 MedTech in Recalibration: Staying Ahead in Regulation\, AI\, and the Deal Landscape
DESCRIPTION:Sidley\, ISS AG\, and Swiss Medtech invite you to our annual Swiss MedTech afternoon\, bringing together regulators\, industry leaders\, legal thought leaders\, and scientific advisers to exchange insights on the evolving MedTech landscape. \n \n\n\n\nRSVP here. \n\n\n\n2026 is a pivotal year for Swiss and European MedTech. MDR and IVDR revisions are progressing\, while the AI Act timeline for medical devices has been adjusted under the Digital Omnibus agreement. \nAt the same time\, EU simplification initiatives are reshaping sustainability\, digitalization\, and reporting obligations. \nManufacturers also face growing geopolitical and economic pressures\, including supply chain disruption\, trade uncertainty\, and rising costs. \nIn Switzerland\, proposed Swissmedic supervisory fees\, the TPITO revision and the rollout of swissdamed are adding further complexity\, while increased M&A activity continues to reshape the sector. \nKey highlights on the agenda include: \nThe European Regulatory Reset: Navigating MDR/IVDR Revision and Omnibus\nWhat is changing\, what is at stake\, and how Swiss manufacturers should prepare for the next phase of the European regulatory framework. \nOperational Resilience in a Volatile Market Environment\nHow trade tensions\, supply chain dependencies\, sustainability and PFAS-related requirements\, and regulatory change are influencing manufacturing\, sourcing\, and long-term decisions. \nSwitzerland: Additional Economic Pressure on Manufacturers\nSwissmedic supervisory fees\, swissdamed implementation\, proposed TPITO revisions\, and evolving anti-corruption expectations — and what they mean for Swiss manufacturers. \nAI Act: From Uncertainty to Implementation\nThe revised timeline for AI-enabled medical devices and the practical implications for MDSW strategy\, data governance\, and compliance planning. \nStrategic Deals in MedTech\nHow AI\, market access\, supply chain resilience\, and regulatory complexity are reshaping acquisition strategies\, valuations\, and investment decisions. \nWho should attend? \nExecutives\, investors\, in-house counsel\, and regulatory managers interested in and/or facing regulatory issues in Switzerland. \nFor more information or questions\, please contact Geneva Events.
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2026-medtech-in-recalibration-staying-ahead-in-regulation-ai-and-the-deal-landscape/
LOCATION:Casino Bern\, Casinoplatz 1\, 3011\, Bern\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260923
DTSTAMP:20260521T235516
CREATED:20260507T155633Z
LAST-MODIFIED:20260507T155633Z
UID:2718-1790035200-1790121599@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2026
DESCRIPTION:As dealmaking and investment continue to shape the future of life sciences and healthcare\, Sidley will convene senior leaders from pharma\, biotech\, healthcare\, private equity\, and venture capital to explore the forces defining the year ahead. \n \nRSVP here. \nJoin Sidley and industry decision-makers from around the world for this one-day\, in-person program in London\, with a virtual attendance and networking option available for those joining from outside the UK. \nExpect a day of sharp insights\, dynamic discussion\, and valuable networking as we explore how the continued convergence of innovation and capital is driving positive patient outcomes and investment returns. \nView the Sidley Healthcare Investment Conference 2025 highlights.
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2026/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
END:VCALENDAR